Nathan P. Wiederhold
#167,340
Most Influential Person Now
Researcher
Nathan P. Wiederhold's AcademicInfluence.com Rankings
Nathan P. Wiederholdcomputer-science Degrees
Computer Science
#10173
World Rank
#10669
Historical Rank
Computational Linguistics
#2567
World Rank
#2592
Historical Rank
Machine Learning
#4652
World Rank
#4704
Historical Rank
Artificial Intelligence
#5013
World Rank
#5078
Historical Rank
Download Badge
Computer Science
Nathan P. Wiederhold's Degrees
- PhD Computer Science Stanford University
- Masters Computer Science Stanford University
Similar Degrees You Can Earn
Why Is Nathan P. Wiederhold Influential?
(Suggest an Edit or Addition)Nathan P. Wiederhold's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium. (2019) (720)
- Antifungal resistance: current trends and future strategies to combat (2017) (262)
- Pharmacodynamics of caspofungin in a murine model of invasive pulmonary aspergillosis: evidence of concentration-dependent activity. (2004) (202)
- Pharmacodynamics of Polymyxin B against Pseudomonas aeruginosa (2005) (196)
- Detection of Gliotoxin in Experimental and Human Aspergillosis (2005) (182)
- Fungal Planet description sheets: 469–557 (2016) (173)
- Fungal Planet description sheets: 320–370 (2015) (169)
- Fungal Planet description sheets: 400–468 (2016) (156)
- Development of Caspofungin Resistance following Prolonged Therapy for Invasive Candidiasis Secondary to Candida glabrata Infection (2008) (153)
- F901318 represents a novel class of antifungal drug that inhibits dihydroorotate dehydrogenase (2016) (147)
- First Detection of TR34 L98H and TR46 Y121F T289A Cyp51 Mutations in Aspergillus fumigatus Isolates in the United States (2015) (139)
- Attenuation of the Activity of Caspofungin at High Concentrations against Candida albicans: Possible Role of Cell Wall Integrity and Calcineurin Pathways (2005) (135)
- The echinocandin antifungals: an overview of the pharmacology, spectrum and clinical efficacy (2003) (133)
- Antifungal Susceptibilities among Different Serotypes of Cryptococcus gattii and Cryptococcus neoformans (2008) (130)
- Isavuconazole: A Comprehensive Review of Spectrum of Activity of a New Triazole (2010) (123)
- In Vitro Pharmacodynamics of Amphotericin B, Itraconazole, and Voriconazole against Aspergillus, Fusarium, and Scedosporium spp (2005) (112)
- Genome-wide expression profiling reveals genes associated with amphotericin B and fluconazole resistance in experimentally induced antifungal resistant isolates of Candida albicans. (2004) (110)
- Coelomycetous Dothideomycetes with emphasis on the families Cucurbitariaceae and Didymellaceae (2017) (108)
- Antimicrobial breakpoints for gram-negative aerobic bacteria based on pharmacokinetic-pharmacodynamic models with Monte Carlo simulation. (2008) (108)
- Fungal infections in animals: a patchwork of different situations. (2018) (107)
- Identification of a New Class of Antifungals Targeting the Synthesis of Fungal Sphingolipids (2015) (105)
- Frequency and Species Distribution of Gliotoxin-Producing Aspergillus Isolates Recovered from Patients at a Tertiary-Care Cancer Center (2005) (105)
- Fungal Planet description sheets: 558–624 (2017) (103)
- Fungal Planet description sheets: 558–624 (2017) (103)
- International Evaluation of MIC Distributions and Epidemiological Cutoff Value (ECV) Definitions for Fusarium Species Identified by Molecular Methods for the CLSI Broth Microdilution Method (2015) (101)
- Rapid Emergence of Echinocandin Resistance in Candida glabrata Resulting in Clinical and Microbiologic Failure (2013) (95)
- Pharmacodynamic Activity of Amphotericin B Deoxycholate Is Associated with Peak Plasma Concentrations in a Neutropenic Murine Model of Invasive Pulmonary Aspergillosis (2006) (92)
- The antifungal arsenal: alternative drugs and future targets. (2017) (91)
- Toll-deficient Drosophila flies as a fast, high-throughput model for the study of antifungal drug efficacy against invasive aspergillosis and Aspergillus virulence. (2005) (91)
- Impact of New Antifungal Breakpoints on Antifungal Resistance in Candida Species (2014) (90)
- Cladosporium Species Recovered from Clinical Samples in the United States (2015) (89)
- The Antifungal Pipeline: Fosmanogepix, Ibrexafungerp, Olorofim, Opelconazole, and Rezafungin (2021) (86)
- The Changing Epidemiology of Oropharyngeal Candidiasis in Patients with HIV/AIDS in the Era of Antiretroviral Therapy (2012) (84)
- Molecular diagnostics in medical mycology (2018) (79)
- Genomewide Expression Profile Analysis of the Candida glabrata Pdr1 Regulon (2010) (76)
- In Vivo Efficacy of Anidulafungin and Caspofungin against Candida glabrata and Association with In Vitro Potency in the Presence of Sera (2007) (75)
- Increases in SLT2 Expression and Chitin Content Are Associated with Incomplete Killing of Candida glabrata by Caspofungin (2007) (71)
- New species of Cladosporium associated with human and animal infections (2016) (70)
- Attenuation of echinocandin activity at elevated concentrations: a review of the paradoxical effect (2007) (69)
- Mutations in hmg1, Challenging the Paradigm of Clinical Triazole Resistance in Aspergillus fumigatus (2019) (69)
- Dihydroorotate dehydrogenase inhibitor F901318 has potent in vitro activity against Scedosporium species and Lomentospora prolificans (2017) (69)
- Phylogeny of the Clinically Relevant Species of the Emerging Fungus Trichoderma and Their Antifungal Susceptibilities (2014) (68)
- Effect of Amphotericin B and Micafungin Combination on Survival, Histopathology, and Fungal Burden in Experimental Aspergillosis in the p47phox−/− Mouse Model of Chronic Granulomatous Disease (2006) (68)
- Invasive Aspergillosis in Patients with Hematologic Malignancies (2003) (66)
- Screening of Antibacterial and Antifungal Activities of Ten Medicinal Plants from Ghana (2004) (66)
- In Vitro Antifungal Activity of Isavuconazole against 345 Mucorales Isolates Collected at Study Centers in Eight Countries (2009) (65)
- Multicenter Evaluation of the Vitek MS v3.0 System for the Identification of Filamentous Fungi (2017) (64)
- Repurposing auranofin as an antifungal: In vitro activity against a variety of medically important fungi (2017) (63)
- Development of High-Level Echinocandin Resistance in a Patient With Recurrent Candida auris Candidemia Secondary to Chronic Candiduria (2019) (63)
- Screening a Repurposing Library for Inhibitors of Multidrug-Resistant Candida auris Identifies Ebselen as a Repositionable Candidate for Antifungal Drug Development (2018) (62)
- Phylogenomic analysis of a 55.1 kb 19-gene dataset resolves a monophyletic Fusarium that includes the Fusarium solani Species Complex. (2020) (60)
- Interlaboratory and Interstudy Reproducibility of a Novel Lateral-Flow Device and Influence of Antifungal Therapy on Detection of Invasive Pulmonary Aspergillosis (2012) (59)
- Caspofungin Dose Escalation for Invasive Candidiasis Due to Resistant Candida albicans (2011) (58)
- Antibacterial activity of linezolid and vancomycin in an in vitro pharmacodynamic model of gram-positive catheter-related bacteraemia. (2005) (57)
- The Celecoxib Derivative AR-12 Has Broad-Spectrum Antifungal Activity In Vitro and Improves the Activity of Fluconazole in a Murine Model of Cryptococcosis (2016) (55)
- In vitro activity of isavuconazole against Trichosporon, Rhodotorula, Geotrichum, Saccharomyces and Pichia species. (2009) (55)
- The Investigational Fungal Cyp51 Inhibitor VT-1129 Demonstrates Potent In Vitro Activity against Cryptococcus neoformans and Cryptococcus gattii (2016) (55)
- A Reference Laboratory Experience of Clinically Achievable Voriconazole, Posaconazole, and Itraconazole Concentrations within the Bloodstream and Cerebral Spinal Fluid (2013) (55)
- Pyrosequencing To Detect Mutations in FKS1 That Confer Reduced Echinocandin Susceptibility in Candida albicans (2008) (54)
- Amphotericin B deoxycholate versus liposomal amphotericin B: Effects on kidney function (2008) (54)
- Paradoxical echinocandin activity: a limited in vitro phenomenon? (2009) (53)
- The echinocandin micafungin: a review of the pharmacology, spectrum of activity, clinical efficacy and safety (2007) (53)
- Redefining Microascus, Scopulariopsis and allied genera (2015) (53)
- Emergence of Azole Resistance in Aspergillus (2015) (53)
- In Vivo Efficacy of Aerosolized Nanostructured Itraconazole Formulations for Prevention of Invasive Pulmonary Aspergillosis (2006) (52)
- Efficacy of Liposomal Amphotericin B and Posaconazole in Intratracheal Models of Murine Mucormycosis (2013) (52)
- Dry powder insufflation of crystalline and amorphous voriconazole formulations produced by thin film freezing to mice. (2012) (52)
- Blastomyces helicus, a New Dimorphic Fungus Causing Fatal Pulmonary and Systemic Disease in Humans and Animals in Western Canada and the United States (2018) (51)
- Characterization and pharmacokinetic analysis of aerosolized aqueous voriconazole solution. (2009) (50)
- Comparison of Lateral Flow Technology and Galactomannan and (1→3)-β-d-Glucan Assays for Detection of Invasive Pulmonary Aspergillosis (2009) (50)
- No to Neocosmospora: Phylogenomic and Practical Reasons for Continued Inclusion of the Fusarium solani Species Complex in the Genus Fusarium (2020) (48)
- Review of the Novel Investigational Antifungal Olorofim (2020) (48)
- Detection of triazole resistance among Candida species by matrix-assisted laser desorption/ionization-time of flight mass spectrometry (MALDI-TOF MS). (2015) (48)
- Rezafungin (CD101) demonstrates potent in vitro activity against Aspergillus, including azole-resistant Aspergillus fumigatus isolates and cryptic species (2018) (48)
- The Investigational Agent E1210 Is Effective in Treatment of Experimental Invasive Candidiasis Caused by Resistant Candida albicans (2014) (47)
- Identification and Antifungal Susceptibility of Penicillium-Like Fungi from Clinical Samples in the United States (2016) (46)
- Aerosolized nanostructured itraconazole as prophylaxis against invasive pulmonary aspergillosis. (2007) (45)
- Coelomycetous Fungi in the Clinical Setting: Morphological Convergence and Cryptic Diversity (2016) (45)
- The solubility ceiling: a rationale for continuous infusion amphotericin B therapy? (2003) (44)
- The Fungal Cyp51-Specific Inhibitor VT-1598 Demonstrates In Vitro and In Vivo Activity against Candida auris (2018) (44)
- Inhaled Voriconazole for Prevention of Invasive Pulmonary Aspergillosis (2009) (44)
- Fungal-specific Cyp51 inhibitor VT-1598 demonstrates in vitro activity against Candida and Cryptococcus species, endemic fungi, including Coccidioides species, Aspergillus species and Rhizopus arrhizus (2018) (43)
- Fosmanogepix (APX001) Is Effective in the Treatment of Immunocompromised Mice Infected with Invasive Pulmonary Scedosporiosis or Disseminated Fusariosis (2019) (43)
- In Vitro Pharmacodynamics of Anidulafungin and Caspofungin against Candida glabrata Isolates, Including Strains with Decreased Caspofungin Susceptibility (2006) (43)
- In vitro characterization and pharmacokinetics in mice following pulmonary delivery of itraconazole as cyclodextrin solubilized solution. (2010) (43)
- Veterinary Fusarioses within the United States (2016) (42)
- Evaluation of VT-1161 for Treatment of Coccidioidomycosis in Murine Infection Models (2015) (41)
- Global guideline for the diagnosis and management of rare yeast infections: an initiative of the ECMM in cooperation with ISHAM and ASM. (2021) (41)
- Pharmacokinetics and safety of posaconazole delayed-release tablets for invasive fungal infections (2015) (39)
- Drug delivery strategies for improved azole antifungal action (2008) (39)
- Aspergillus fumigatus and pan-azole resistance: who should be concerned? (2020) (38)
- Isavuconazole Is Effective for the Treatment of Experimental Cryptococcal Meningitis (2016) (38)
- Monotherapy or combination therapy of isavuconazole and micafungin for treating murine mucormycosis (2017) (38)
- The Orotomide Olorofim Is Efficacious in an Experimental Model of Central Nervous System Coccidioidomycosis (2018) (38)
- Emergomyces canadensis, a Dimorphic Fungus Causing Fatal Systemic Human Disease in North America (2018) (37)
- The genome of opportunistic fungal pathogen Fusarium oxysporum carries a unique set of lineage-specific chromosomes (2020) (37)
- Fosmanogepix (APX001) Is Effective in the Treatment of Pulmonary Murine Mucormycosis Due to Rhizopus arrhizus (2020) (37)
- Oral glucan synthase inhibitor SCY-078 is effective in an experimental murine model of invasive candidiasis caused by WT and echinocandin-resistant Candida glabrata (2018) (37)
- VT-1161 Protects Immunosuppressed Mice from Rhizopus arrhizus var. arrhizus Infection (2015) (36)
- Efficacy of Delayed Therapy with Fosmanogepix (APX001) in a Murine Model of Candida auris Invasive Candidiasis (2019) (36)
- In Vitro Activity of Isavuconazole against Opportunistic Fungal Pathogens from Two Mycology Reference Laboratories (2018) (35)
- Occurrence of Ochroconis and Verruconis Species in Clinical Specimens from the United States (2014) (35)
- Culture-Independent Molecular Methods for Detection of Antifungal Resistance Mechanisms and Fungal Identification (2017) (35)
- The Novel Fungal Cyp51 Inhibitor VT-1598 Is Efficacious in Experimental Models of Central Nervous System Coccidioidomycosis Caused by Coccidioides posadasii and Coccidioides immitis (2018) (34)
- Murine airway histology and intracellular uptake of inhaled amorphous itraconazole. (2007) (33)
- Large-Scale Evaluation of In Vitro Amphotericin B, Triazole, and Echinocandin Activity against Coccidioides Species from U.S. Institutions (2017) (33)
- Limited Activity of Miltefosine in Murine Models of Cryptococcal Meningoencephalitis and Disseminated Cryptococcosis (2012) (33)
- Evaluation of Etest Method for Determining Isavuconazole MICs against Cryptococcus gattii and Cryptococcus neoformans (2008) (33)
- Phylogeny and taxonomic revision of Microascaceae with emphasis on synnematous fungi (2016) (33)
- Loss of C-5 Sterol Desaturase Activity Results in Increased Resistance to Azole and Echinocandin Antifungals in a Clinical Isolate of Candida parapsilosis (2017) (33)
- Recommended Education for Pharmacists as Competitive Clinical Scientists (2009) (33)
- Murine model of invasive aspergillosis. (2005) (33)
- Isavuconazole as Primary Anti-Fungal Prophylaxis in Patients with Acute Myeloid Leukemia or Myelodysplastic Syndrome: An Open-Label, Prospective, Phase II Study. (2020) (33)
- Re-evaluation of Mycoleptodiscus species and morphologically similar fungi (2019) (32)
- Evaluation of aminocandin and caspofungin against Candida glabrata including isolates with reduced caspofungin susceptibility. (2008) (32)
- Detection and Measurement of Fungal Burden in a Guinea Pig Model of Invasive Pulmonary Aspergillosis by Novel Quantitative Nested Real-Time PCR Compared with Galactomannan and (1,3)-β-d-Glucan Detection (2011) (32)
- Antifungal activity against Scedosporium species and novel assays to assess antifungal pharmacodynamics against filamentous fungi. (2009) (32)
- Update from the Laboratory: Clinical Identification and Susceptibility Testing of Fungi and Trends in Antifungal Resistance. (2016) (32)
- The novel arylamidine T-2307 demonstrates in vitro and in vivo activity against echinocandin-resistant Candida glabrata. (2016) (31)
- Disruption of the Transcriptional Regulator Cas5 Results in Enhanced Killing of Candida albicans by Fluconazole (2014) (30)
- Combat-Related Pythium aphanidermatum Invasive Wound Infection: Case Report and Discussion of Utility of Molecular Diagnostics (2015) (29)
- Echinocandin Resistance in Candida Species: a Review of Recent Developments (2016) (29)
- Drug delivery strategies for improved azole antifungal action. (2008) (28)
- A murine model of Cryptococcus gattii meningoencephalitis. (2012) (27)
- Species diversity of Aspergillus section Versicolores in clinical samples and antifungal susceptibility. (2016) (26)
- In Vitro Activities of the Novel Investigational Tetrazoles VT-1161 and VT-1598 Compared to the Triazole Antifungals against Azole-Resistant Strains and Clinical Isolates of Candida albicans (2019) (26)
- In vitro pharmacodynamics of rapid versus continuous infusion of amphotericin B deoxycholate against Candida species in the presence of human serum albumin. (2006) (25)
- Pithomyces species (Montagnulaceae) from clinical specimens: identification and antifungal susceptibility profiles. (2014) (25)
- Assessment of Serum (1→3)-β-d-Glucan Concentration as a Measure of Disease Burden in a Murine Model of Invasive Pulmonary Aspergillosis (2007) (25)
- The Novel Arylamidine T-2307 Maintains In Vitro and In Vivo Activity against Echinocandin-Resistant Candida albicans (2014) (25)
- Shielding the Next Generation: Symbiotic Bacteria from a Reproductive Organ Protect Bobtail Squid Eggs from Fungal Fouling (2019) (25)
- Luliconazole Demonstrates Potent In Vitro Activity against Dermatophytes Recovered from Patients with Onychomycosis (2014) (25)
- Fatal disseminated Rasamsonia infection in cystic fibrosis post-lung transplantation. (2017) (24)
- Four new species of Talaromyces from clinical sources (2017) (24)
- Prophylactic Treatment with VT-1161 Protects Immunosuppressed Mice from Rhizopus arrhizus var. arrhizus Infection (2017) (24)
- Paradoxical antifungal activity and structural observations in biofilms formed by echinocandin-resistant Candida albicans clinical isolates. (2014) (23)
- Efficacy of Posaconazole as Treatment and Prophylaxis against Fusarium solani (2010) (22)
- The Novel Arylamidine T-2307 Demonstrates In Vitro and In Vivo Activity against Candida auris (2019) (22)
- Therapeutic and prophylactic efficacy of aminocandin (IP960) against disseminated candidiasis in mice. (2008) (22)
- In Vivo Efficacy of VT-1129 against Experimental Cryptococcal Meningitis with the Use of a Loading Dose-Maintenance Dose Administration Strategy (2018) (21)
- What's new in antifungals: an update on the in-vitro activity and in-vivo efficacy of new and investigational antifungal agents (2015) (20)
- The importance of antimicrobial resistance in medical mycology (2022) (20)
- Multicenter Evaluation of the New Vitek 2 Yeast Susceptibility Test Using New CLSI Clinical Breakpoints for Fluconazole (2014) (20)
- Reduced Antifungal Susceptibility of Vulvovaginal Candida Species at Normal Vaginal pH Levels: Clinical Implications (2018) (19)
- The Tetrazole VT-1161 Is a Potent Inhibitor of Trichophyton rubrum through Its Inhibition of T. rubrum CYP51 (2017) (19)
- In Vitro Activity of Essential Oils Against Gram-Positive and Gram-Negative Clinical Isolates, Including Carbapenem-Resistant Enterobacteriaceae (2019) (19)
- A case of Exophiala oligosperma successfully treated with voriconazole☆ (2013) (19)
- Comparison of anidulafungin's and fluconazole's in vivo activity in neutropenic and non-neutropenic models of invasive candidiasis. (2012) (19)
- Prophylactic efficacy of single dose pulmonary administration of amphotericin B inhalation powder in a guinea pig model of invasive pulmonary aspergillosis. (2012) (19)
- Multilocus Phylogeny and Antifungal Susceptibility of Aspergillus Section Circumdati from Clinical Samples and Description of A. pseudosclerotiorum sp. nov (2017) (19)
- Epidemiology and Antifungal Susceptibilities of Mucoralean Fungi in Clinical Samples from the United States (2021) (18)
- Pulmonary Fungal Infection Caused by Neoscytalidium dimidiatum (2015) (18)
- The Fungal Cyp51 Inhibitor VT-1129 Is Efficacious in an Experimental Model of Cryptococcal Meningitis (2018) (18)
- Enterobacter cloacae Ventriculitis Successfully Treated with Cefepime and Gentamicin: Case Report and Review of the Literature (2003) (18)
- Dynamics of Mixed–Candida Species Biofilms in Response to Antifungals (2018) (17)
- Comparison of Nonculture Blood-Based Tests for Diagnosing Invasive Aspergillosis in an Animal Model (2016) (17)
- Clinical, Morphological, and Molecular Characterization of Penicillium canis sp. nov., Isolated from a Dog with Osteomyelitis (2014) (17)
- Attenuation of Itraconazole Fungicidal Activity following Preexposure of Aspergillus fumigatus to Fluconazole (2003) (17)
- Microbiology and epidemiology of oral yeast colonization in hemopoietic progenitor cell transplant recipients. (2013) (16)
- Dose tolerability of chronically inhaled voriconazole solution in rodents. (2009) (16)
- Prophylaxis with Isavuconazole or Posaconazole Protects Immunosuppressed Mice from Pulmonary Mucormycosis (2017) (16)
- Impact of the Major Candida glabrata Triazole Resistance Determinants on the Activity of the Novel Investigational Tetrazoles VT-1598 and VT-1161 (2019) (16)
- Differential Thermotolerance Adaptation between Species of Coccidioides (2020) (16)
- Ibrexafungerp Demonstrates In Vitro Activity against Fluconazole-Resistant Candida auris and In Vivo Efficacy with Delayed Initiation of Therapy in an Experimental Model of Invasive Candidiasis (2021) (16)
- Antibacterials as Adjuncts to Incision and Drainage for Adults with Purulent Methicillin-Resistant Staphylococcus aureus (MRSA) Skin Infections (2012) (15)
- Isolation and characterisation of the fungus Spiromastix asexualis sp. nov. from discospondylitis in a German Shepherd dog, and review of Spiromastix with the proposal of the new order Spiromastixales (Ascomycota) (2014) (15)
- Antifungal Susceptibility and Clinical Outcome in Neonatal Candidiasis (2018) (15)
- Species of Aspergillus section Aspergillus from clinical samples in the United States (2018) (14)
- Phaeohyphomycosis resulting in obstructive tracheitis in three green sea turtles Chelonia mydas stranded along the Florida coast. (2015) (14)
- Nanopore Sequencing of the Fungal Intergenic Spacer Sequence as a Potential Rapid Diagnostic Assay (2020) (14)
- Efficacy of the Investigational Echinocandin ASP9726 in a Guinea Pig Model of Invasive Pulmonary Aspergillosis (2015) (14)
- Extended-Interval Dosing of Rezafungin against Azole-Resistant Aspergillus fumigatus (2019) (14)
- Morphological and Molecular Characterization of Exophiala polymorpha sp. nov. Isolated from Sporotrichoid Lymphocutaneous Lesions in a Patient with Myasthenia Gravis (2015) (13)
- In vitro activity of olorofim against clinical isolates of the Fusarium oxysporum and Fusarium solani species complexes (2021) (13)
- Cryptic Aspergillus from clinical samples in the USA and description of a new species in section Flavipedes (2018) (13)
- Effect of Amphotericin B and Micafungin Combination on Survival, Histopathology, and Fungal Burden in Experimental Aspergillosis in the p47 / Mouse Model of Chronic Granulomatous Disease (2006) (13)
- Micafungin in the treatment of invasive candidiasis and invasive aspergillosis (2009) (13)
- Acrophialophora, a Poorly Known Fungus with Clinical Significance (2015) (13)
- The Carbohydrate Lectin Receptor Dectin-1 Mediates the Immune Response to Exserohilum rostratum (2016) (12)
- Review of T-2307, an Investigational Agent That Causes Collapse of Fungal Mitochondrial Membrane Potential (2021) (12)
- Influence of Serum and Albumin on Echinocandin In Vitro Potency and Pharmacodynamics (2013) (11)
- Pentamidine Is Active in a Neutropenic Murine Model of Acute Invasive Pulmonary Fusariosis (2006) (11)
- Multifocal Rhizopus microsporus lung infection following brush clearing (2014) (11)
- PHARMACOKINETICS OF ORALLY ADMINISTERED VORICONAZOLE IN AFRICAN PENGUINS (SPHENISCUS DEMERSUS) AFTER SINGLE AND MULTIPLE DOSES (2017) (11)
- APX001A Protects Immunosuppressed Mice from Rhizopus delemar Infection (2017) (11)
- Antifungal Susceptibility Testing: A Primer for Clinicians (2021) (11)
- New acremonium-like species in the Bionectriaceae and Plectosphaerellaceae (2017) (11)
- Invasive candidiasis: investigational drugs in the clinical development pipeline and mechanisms of action (2022) (11)
- Antifungal Use in Veterinary Practice and Emergence of Resistance (2018) (11)
- Rasamsonia sp: An emerging infection amongst chronic granulomatous disease patients. A case of disseminated infection by a putatively novel Rasamsonia argillacea species complex involving the heart (2019) (11)
- Emerging Fungal Infections: New Species, New Names, and Antifungal Resistance (2021) (11)
- Antifungal Resistance Testing and Implications for Management (2019) (11)
- Animal Models In Mycology: What Have We Learned Over The Past 30 Years (2012) (10)
- Diversity of Veronaea botryosa from different hosts and evaluation of laboratory challenge models for phaeohyphomycosis in Acipenser transmontanus. (2017) (10)
- From the Clinical Mycology Laboratory: New Species and Changes in Fungal Taxonomy and Nomenclature (2018) (10)
- Effects of Treated versus Untreated Polystyrene on Caspofungin In Vitro Activity against Candida Species (2016) (10)
- Paravertebral Mushroom: Identification of a Novel Species of Phellinus as a Human Pathogen in Chronic Granulomatous Disease (2014) (10)
- Effect of Antifungal Treatment in a Diet-Based Murine Model of Disseminated Candidiasis Acquired via the Gastrointestinal Tract (2016) (10)
- First Report of Westerdykella dispersa as a Cause of an Angioinvasive Fungal Infection in a Neutropenic Host (2014) (9)
- Modified release itraconazole amorphous solid dispersion to treat Aspergillus fumigatus: importance of the animal model selection (2017) (9)
- The Black Yeasts: an Update on Species Identification and Diagnosis (2018) (9)
- Erratum for Mor et al., “Identification of a New Class of Antifungals Targeting the Synthesis of Fungal Sphingolipids” (2018) (9)
- First Human Case of Fungal Keratitis Caused by a Putatively Novel Species of Lophotrichus (2015) (9)
- Schizophyllum radiatum, an Emerging Fungus from Human Respiratory Tract (2016) (9)
- Novel Penicillium species causing disseminated disease in a Labrador Retriever dog. (2020) (9)
- Invasive Fungal Infection Due to Triadelphia pulvinata in a Patient with Acute Myeloid Leukemia (2013) (9)
- Novel Paranannizziopsis species in a Wagler's viper (Tropidolaemus wagleri), tentacled snakes (Erpeton tentaculatum), and a rhinoceros snake (Rhynchophis boulengeri) in a zoological collection. (2018) (8)
- Manogepix, the Active Moiety of the Investigational Agent Fosmanogepix, Demonstrates In Vitro Activity against Members of the Fusarium oxysporum and Fusarium solani Species Complexes (2021) (8)
- Comparison of MICs of Fluconazole and Flucytosine When Dissolved in Dimethyl Sulfoxide or Water (2013) (8)
- Disseminated Conidiobolus incongruus in a dog: A case report and literature review (2015) (8)
- Voriconazole and posaconazole therapy for experimental Candida lusitaniae infection. (2016) (8)
- Multi-locus sequence typing provides epidemiological insights for diseased sharks infected with fungi belonging to the Fusarium solani species complex (2018) (7)
- Species Distribution and Antifungal Susceptibilities of Aspergillus Section Fumigati Isolates in Clinical Samples from the United States (2022) (7)
- New Species Spiromastigoides albida from a Lung Biopsy (2017) (7)
- Fungal Keratitis Secondary to Trametes betulina: A Case Report and Review of Literature (2017) (7)
- Genomic Diversity across Candida auris Clinical Isolates Shapes Rapid Development of Antifungal Resistance In Vitro and In Vivo (2022) (7)
- Multilaboratory Evaluation of In Vitro Antifungal Susceptibility Testing of Dermatophytes for ME1111 (2015) (6)
- Caspofungin for the Treatment of Immunocompromised and Severely Ill Children and Neonates with Invasive Fungal Infections (2012) (6)
- New Perspectives on Antimicrobial Agents: Isavuconazole (2022) (6)
- Pharmacodynamics, Mechanisms of Action and Resistance, and Spectrum of Activity of New Antifungal Agents (2022) (6)
- Examination of Fluconazole-Induced Alopecia in an Animal Model and Human Cohort (2018) (5)
- First report of human infection caused by Colletotrichum chlorophyti occurring in a post-corneal transplant patient with endophthalmitis (2021) (5)
- Development of a Candida glabrata dominant nutritional transformation marker utilizing the Aspergillus nidulans acetamidase gene (amdS). (2016) (5)
- Rapid and Low-Cost Culture-Based Method for Diagnosis of Mucormycosis Using a Mouse Model (2020) (5)
- Efficacy and Associated Drug Exposures of Isavuconazole and Fluconazole in an Experimental Model of Coccidioidomycosis (2021) (5)
- Blastomyces helicus, an Emerging Dimorphic Fungal Pathogen Causing Fatal Pulmonary and Disseminated Disease in Humans and Animals in Western Canada and United States (2017) (5)
- Prolyl endopeptidase activity in bronchoalveolar lavage fluid: a novel diagnostic biomarker in a guinea pig model of invasive pulmonary aspergillosis. (2013) (5)
- Evaluation of Sex Differences in Murine Diabetic Ketoacidosis and Neutropenic Models of Invasive Mucormycosis (2021) (4)
- Fungal arthritis secondary to Colletotrichum gloeosporioides (2015) (4)
- Loss of in vitro resistance in Candida glabrata following discontinuation of fluconazole prophylaxis in a hematopoietic stem cell transplantation patient. (2010) (4)
- Gastrointestinal pythiosis with concurrent presumptive gastrointestinal basidiobolomycosis in a Boxer dog. (2019) (4)
- Voriconazole minimum inhibitory concentrations are predictive of treatment outcome in experimental murine infections by Candida glabrata. (2016) (4)
- Penicillium-like fungi from clinical samples in the USA and their antifungal 1 susceptibility 2 3 (2016) (4)
- Retrospective study of phaeohyphomycosis in aquarium-housed fish, with first descriptions of Exophiala lecanii-corni and Neodevriesia cladophorae in fish. (2021) (4)
- Efficacy of echinocandins against murine infections by Diutina (Candida) rugosa. (2016) (3)
- Pharmacology, in vitro activity, and in vivo efficacy of new antifungal agents (2009) (3)
- Three new Curvularia species from clinical and environmental sources (2020) (3)
- Update on Therapeutic Drug Monitoring of Antifungals for the Prophylaxis and Treatment of Invasive Fungal Infections (2017) (3)
- Genomic characterization of Parengyodontium americanum sp. Nov. (2020) (3)
- Case Report: Successful Management of Conidiobolus Lamprauges Rhinitis in a Dog (2021) (3)
- Multiple Brain Abscesses Caused by Trichosporon inkin in a Patient with X-Linked Chronic Granulomatous Disease (CGD) Successfully Treated with Antifungal Therapy (2017) (3)
- Corrigendum: Fungal infections in animals: a patchwork of different situations. (2018) (3)
- Assessment of Aspergillus fumigatus in Guinea Pig Bronchoalveolar Lavages and Pulmonary Tissue by Culture and Realtime Polymerase Chain Reaction Studies (2012) (3)
- Isavuconazole (ISAV) As Primary Anti-Fungal Prophylaxis in Acute Myeloid Leukemia or Myelodysplastic Syndrome: An Open-Label, Prospective Study (2018) (3)
- Ustilago echinata: Infection in a Mixed Martial Artist Following an Open Fracture (2016) (2)
- Trichosporonosis Presenting as an Exophytic Cutaneous Mass Lesion (2020) (2)
- Variability of Hydroxy-Itraconazole in Relation to Itraconazole Bloodstream Concentrations (2021) (2)
- Dihydroorotate dehydrogenase inhibitor olorofim has potent in vitro activity against Microascus/Scopulariopsis, Rasamsonia, Penicillium and Talaromyces species (2022) (2)
- Moxifloxacin: A review of its in vitro activity, clinical efficacy, and adverse effects (2003) (2)
- Fungal Planet description sheets: 458–624 (2016) (2)
- Two new species of Gloniopsis (Hysteriales, Ascomycota) from clinical specimens: Morphological and molecular characterisation (2019) (2)
- Schwanniomyces etchellsii: an unusual cause of fungemia in a patient with cholecystitis. (2016) (2)
- A revision of malbranchea-like fungi from clinical specimens in the United States of America reveals unexpected novelty (2021) (2)
- Disseminated Rasamsonia argillacea species complex infections in 8 dogs (2021) (2)
- and the Influence of Antifungal Therapy on the Detection of Invasive Pulmonary 2 (2012) (2)
- Polymeric Iron Chelator with Enhanced Iron Affinity as a Broad-Spectrum Antifungal Agent (2021) (2)
- Pseudocanariomyces americanus, gen. nov., sp. nov., A New Thielavia-Like Species in the Chaetomiaceae: Identification and Management of a Prosthetic Hip Infection (2021) (2)
- Invasive Pulmonary Aspergillosis: Therapeutic and Prophylactic Strategies (2007) (2)
- Rigidoporus corticola Colonization and Invasive Fungal Disease in Immunocompromised Patients, United States (2022) (1)
- Invasive Rhinosinusitis Caused by Lasiodiplodia theobromae in an Allogeneic Hematopoietic Cell Transplant Recipient Case Report and Review of Literature (2018) (1)
- Probable case of Cephalotheca foveolata bloodstream infection (2015) (1)
- Assessment of Serum (1 3 3)- (cid:2) - D -Glucan Concentration as a Measure of Disease Burden in a Murine Model of Invasive Pulmonary Aspergillosis (cid:1) (2008) (1)
- Lung Abscess Due to Aspergillus lentulus and Pseudomonas aeruginosa in a Patient With Granulomatosis With Polyangiitis: Case and Review of the Literature (2017) (1)
- A Recombinant Multivalent Vaccine (rCpa1) Induces Protection for C57BL/6 and HLA Transgenic Mice Against Pulmonary Infection with Both Species of Coccidioides (2021) (1)
- Retinoic Acid Is Not Involved in Fluconazole-Induced Alopecia: Evaluation in a Human Cohort and Rat Model (2016) (1)
- The Brief Case: Histoplasma duboisii—an Infection with a Rare Organism Presenting as an Abdominal Mass (2022) (1)
- Diagnosis from Tissue: Histology and Identification (2022) (1)
- The Promise of Lung Organoids for Growth and Investigation of Pneumocystis Species (2021) (1)
- First Reported Case of Invasive Cutaneous Penicillium cluniae Infection in a Patient With Acute Myelogenous Leukemia: A Case Report and Literature Review (2021) (1)
- Fusarium abutilonis and F. guadeloupense, two novel species in the Fusarium buharicum clade supported by multilocus molecular phylogenetic analyses (2022) (1)
- Model of Chronic Granulomatous Disease Mouse − / − phox Aspergillosis in the p 47 and Fungal Burden in Experimental Combination on Survival , Histopathology , Effect of Amphotericin B and Micafungin (2006) (1)
- Clinical mycology today: A synopsis of the mycoses study group education and research consortium (MSGERC) second biennial meeting, September 27-30, 2018, Big Sky, Montana, a proposed global research agenda. (2020) (1)
- In vitro Susceptibility Testing of Essential Oils against Gram-positive and Gram-negative Clinical Isolates, including Carbapenem-resistant Enterobacteriaceae (CRE) (2017) (1)
- In vitro Activity of Fosfomycin, Alone and Combined with Cefepime and Meropenem, Against Carbapenemase-Producing Gram-Negative Bacteria (2017) (1)
- 2393. Evaluation of Antifungal Treatment in a Neutropenic Mouse Model of Scedosporiosis (2018) (1)
- Reply to “Interlaboratory and Interstudy Reproducibility of a Novel Lateral-Flow Device: a Statistical Issue” (2013) (1)
- Phialophora chinensis fungal keratitis: An initial case report and species identification (2023) (1)
- Pulmonary infection secondary to Blastobotrys raffinosifermentans in a cystic fibrosis patient: Review of the literature (2021) (1)
- Use of nested quantitative PCR for monitoring of fungal burdenin guinea pig model of invasive aspergillosis (2010) (1)
- Fungal Infections in Immunocompromised Hosts (2019) (1)
- A case of phaeohyphomycosis caused by Exophiala oligosperma in a renal transplant patient successfully treated with posaconazole (2015) (1)
- Stachybotrys eucylindrospora isolated from foreign material following a traumatic eye injury (2014) (1)
- Rare malbranchea-like fungal isolates from clinical specimens in United States of America. (2021) (1)
- 1954. In vivo Efficacy of Delayed Therapy with the Novel Inositol Acyltransferase Inhibitor Fosmanogepix (APX001) in a Murine Model of Candida auris Invasive Candidiasis (2019) (1)
- The Antifungal and Anti-Pneumocystis Activities of the Novel Compound A3IS (Mycosinate) (2022) (1)
- 2121. Isavuconazole (ISAV) as Primary Anti-Fungal Prophylaxis (PAP) in Patients with Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS): An Open-Label, Prospective Study (2019) (0)
- Making clinical sense of candida and aspergillus susceptibilities (2016) (0)
- S2.3c High-resolution digital DNA melting: a breakthrough in diagnosing IMI? (2022) (0)
- Advanced Molecular Diagnosis of Fungal Infections (2018) (0)
- Molecular diagnostics in medical mycology (2018) (0)
- Answer to December 2021 Photo Quiz (2021) (0)
- Figure 4 from: Iturrieta - González I, Gené J, Wiederhold N, García D (2020) Three new Curvularia species from clinical and environmental sources. MycoKeys 68: 1-21. https://doi.org/10.3897/mycokeys.68.51667 (2020) (0)
- Spiromastigoides asexualis: Phylogenetic Analysis and Evaluation as a Cause of False-Positive Blastomyces DNA Probe Test Results (2020) (0)
- Implications of Evolving and Emerging Pharmacokinetic-Pharmacodynamic Research for Triazoles and Echinocandins (2020) (0)
- Pseudocanariomyces americanus, gen. nov., sp. nov.: Update to the Management of a Periprosthetic Hip Infection (2022) (0)
- Serum 1,3-β-D-Glucan (BG) as a Measure of Disease Burden and Response to Caspofungin (CAS) Therapy in Invasive Pulmonary Aspergillosis (IPA) (2008) (0)
- What’s Old is New: Recognition of New Fungal Pathogens in the Era of Phylogenetics and Changing Taxonomy and Implications for Medical Mycology (2016) (0)
- Book Review: Travel Medicine, 2nd Edition (2009) (0)
- hapE and hmg1 Mutations Are Drivers of cyp51A-Independent Pan-Triazole Resistance in an Aspergillus fumigatus Clinical Isolate (2023) (0)
- Fungal keratitis caused by Coniochaeta mutabilis-A case report. (2023) (0)
- Closing the Brief Case: Histoplasma duboisii—an Infection with a Rare Organism Presenting as an Abdominal Mass (2022) (0)
- Multiple Brain Abscesses Caused by Trichosporon inkin in a Patient with X-Linked Chronic Granulomatous Disease (CGD) Successfully Treated with Antifungal Therapy (2017) (0)
- Figure 3 from: Iturrieta - González I, Gené J, Wiederhold N, García D (2020) Three new Curvularia species from clinical and environmental sources. MycoKeys 68: 1-21. https://doi.org/10.3897/mycokeys.68.51667 (2020) (0)
- [A case of coccidioidomycosis in Turkey imported from the United States of America]. (2017) (0)
- Development and Evaluation of an Experimental Model of Invasive Candidiasis caused by Candida auris (2018) (0)
- Figure 2 from: Iturrieta - González I, Gené J, Wiederhold N, García D (2020) Three new Curvularia species from clinical and environmental sources. MycoKeys 68: 1-21. https://doi.org/10.3897/mycokeys.68.51667 (2020) (0)
- In Vitro Volatile Metabolite Signatures of Common Pathogenic Fusarium Species (2016) (0)
- Phaeohyphomycosis due to Exophiala in Aquarium-Housed Lumpfish (Cyclopterus lumpus): Clinical Diagnosis and Description (2022) (0)
- large, porous inhaled particles Recent advances in pulmonary drug delivery using (2015) (0)
- Species Distribution and Antifungal Susceptibilities of Aspergillus Section Terrei Isolates in Clinical Samples from the United States and Description of Aspergillus pseudoalabamensis sp. nov. (2023) (0)
- Yeasts. (2019) (0)
- Efficacy of the Investigational Echinocandin ASP9726 in a Guinea Pig Model of Invasive Pulmonary Aspergillosis (2015) (0)
- Preclinical Development of MiBIECT, a New Oxadiazolyl-Oxazolidinone Compound Active against Gram-positive Cocci (2015) (0)
- Invasive Rhinosinusitis Caused by Lasiodiplodia theobromae in an Allogeneic Hematopoietic Cell Transplant Recipient Case Report and Review of Literature (2018) (0)
- Case Report Fungal arthritis secondary to Colletotrichum gloeosporioides (2015) (0)
- Candida albicans by Fluconazole Cas5 Results in Enhanced Killing of Disruption of the Transcriptional Regulator (2014) (0)
- Figure 1 from: Iturrieta - González I, Gené J, Wiederhold N, García D (2020) Three new Curvularia species from clinical and environmental sources. MycoKeys 68: 1-21. https://doi.org/10.3897/mycokeys.68.51667 (2020) (0)
- Susceptibilities Trichoderma and Their Antifungal Species of the Emerging Fungus Phylogeny of the Clinically Relevant (2014) (0)
- Ustilago echinata: Infection in a Mixed Martial Artist Following an Open Fracture (2015) (0)
- Acute Myeloid Leukemia Triadelphia pulvinata in a Patient with Invasive Fungal Infection Due to (2013) (0)
- Invasive Microsporum canis causing rhinitis and stomatitis in a cat. (2016) (0)
- Hidden in plain sight: urinary Cryptococcus neoformans missed by routine diagnostics in a patient with acute leukemia (2022) (0)
- Mycology of Onychomycosis (2023) (0)
- Clinical Breakpoints for Fluconazole Yeast Susceptibility Test Using New CLSI Multicenter Evaluation of the New Vitek 2 (2014) (0)
- Aerosolized Voriconazole (VRC) as Prophylaxis against Invasive Pulmonary Aspergillosis (IPA) due to Aspergillus fumigatus (2008) (0)
- Using Antifungal Pharmacodynamics to Improve Patient Outcomes (2010) (0)
- Examining the In Vitro Volatile Metabolite Profile of Pathogenic Scedosporium and Lomentospora Species (2016) (0)
- In Memoriam: Deanna A. Sutton, Ph.D (2017) (0)
- In Vivo Efficacy of Anidulafungin and Caspofungin against Candida glabrata and Association with In Vitro Potency in the Presence of Sera (cid:1) (2007) (0)
- kb 19-gene dataset resolves a monophyletic Fusarium that includes the 2 Fusarium solani Species Complex 3 4 (2020) (0)
- A Novel Exophiala Species Associated With Disseminated Granulomatous Inflammation in a Captive Eastern Hellbender (Cryptobranchus alleganiensis alleganiensis) (2020) (0)
- Fungal Keratitis Secondary to Trametes betulina: A Case Report and Review of Literature (2017) (0)
- Supplementary material 1 from: Iturrieta - González I, Gené J, Wiederhold N, García D (2020) Three new Curvularia species from clinical and environmental sources. MycoKeys 68: 1-21. https://doi.org/10.3897/mycokeys.68.51667 (2020) (0)
- Assessment of Serum ( 1 3 )-β-D-Glucan as a Measure of Disease Burden in a 1 Murine Model of Invasive Pulmonary Aspergillosis 2 3 (2007) (0)
- In Vivo Efficacy of Posaconazole (PSC) against Fusarium solani (FS) with Reduced In Vitro Susceptibility (2008) (0)
- Efficacy of Posaconazole as Treatment and Prophylaxis against Fusarium solani (cid:1) (2010) (0)
- Preface (2019) (0)
- Photo Quiz: You Get What You Get, and Sometimes It’s Tuberculate (2021) (0)
- New acremonium-like species in the Bionectriaceae and Plectosphaerellaceae (2017) (0)
- Antifungal Susceptibility Testing of Dermatophytes (2021) (0)
- Ocurrence of Ochroconis and Verruconis species in clinical specimens from the 1 (2014) (0)
- 1282. Manogepix, the Active Moiety of the Investigational Agent Fosmanogepix, Demonstrates In vitro Activity Against Members of the Fusarium oxysporum and Fusarium solani Species Complexes (2020) (0)
- Erratum for Wiederhold et al., “The Antifungal and Anti-Pneumocystis Activities of the Novel Compound A3IS (Mycosinate)” (2023) (0)
- New Species Spiromastigoides albida from a Lung Biopsy (2017) (0)
- Antifungal Susceptibility of Yeasts and Filamentous Fungi by CLSI Broth Microdilution Testing. (2023) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Nathan P. Wiederhold?
Nathan P. Wiederhold is affiliated with the following schools:
